Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality

Human Immunology

Volumn 73, Issue 5, 2012, Pages 580-584

  Cao, Bangwei ^a   Dong, Shuo ^b   Su, Qiang ^a   Yan, Bo ^c   Zhen, Hongchao ^a   Yuan, Zhenyan ^a   Liu, Xiaolin ^d   Li, Yan ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c University of Texas Health Science Center   (United States)

^d SHANDONG UNIVERSITY   (China)

Author keywords

LMP2 gene; Lung cancer; Polymorphism

Indexed keywords

ARGININE; LOW MOLECULAR MASS PROTEASE 2; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GENETICS; CANCER RISK; CANCER STAGING; CHINESE; CODON; CONTROLLED STUDY; DNA SEQUENCE; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BASE SEQUENCE; CARCINOMA; CASE-CONTROL STUDIES; CHINA; CODON; CYSTEINE ENDOPEPTIDASES; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860246698     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.005     Document Type: Article

References (21)

1. Van't Westeinde S.C., van Klaveren R.J. Screening and early detection of lung cancer. Cancer J 2011, 17:3-10.
2. Schütt P., Schütt B., Switala M., Bauer S., Stamatis G., Opalka B., et al. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol 2010, 71:489-495.
3. Chen W., Li Z., Bai L., Lin Y. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci 2011, 16:1172-1185.
4. Konishi J., Yamazaki K., Yokouchi H., Shinagawa N., Iwabuchi K., Nishimura M. The characteristics of human NKT cells in lung cancer-CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Hum Immunol 2004, 65:1377-1388.
5. Dissemond J., Goette P., Moers J., Lindeke A., Goos M., Ferrone S., et al. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression. Melanoma Res 2003, 13:371-377.
6. Ho Y.K., Bargagna-Mohan P., Wehenkel M., Mohan R., Kim K.B. LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem Biol 2007, 14:419-430.
7. Rock K.L., York I.A., Saric T., Goldberg A.L. Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol 2002, 80:1-70.
8. Camarena A., Aquino-Galvez A., Falfán-Valencia R., Sánchez G., Montaño M., Ramos C., et al. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis. Respir Med 2010, 104:889-894.
9. Casp C.B., She J.X., McCormack W.T. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun 2003, 4:492-499.
10. Vargas-Alarcón G., Gamboa R., Zuñiga J., Fragoso J.M., Hernández-Pacheco G., Londoño J., et al. Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 2004, 65:1437-1442.
11. Deshpande A., Wheeler C.M., Hunt W.C., Peyton C.L., White P.S., Valdez Y.E., et al. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer. J Infect Dis 2008, 197:371-381.
12. Xu C., Qi S., Gao L., Cui H., Liu M., Yang H., et al. Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population. J Clin Immunol 2007, 27:534-541.
13. Krämer U., Illig T., Grune T., Krutmann J., Esser C. Strong associations of psoriasis with antigen processing LMP and transport genes TAP differ by gender and phenotype. Genes Immun 2007, 8:513-517.
14. Monaco J.J. A molecular model of MHC class-I-restricted antigen processing. Immunol Today 1992, 13:173-179.
15. Khan M.A., Oubrahim H., Stadtman E.R. Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. Proc Natl Acad Sci U S A 2004, 101:11560-11565.
16. Ceppellini R., Frumento G., Ferrara G.B., Tosi R., Chersi A., Pernis B. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature 1989, 339:392-394.
17. *. Clin Endocrinol Oxf 1999, 51:115-118. 0501.
18. Vinasco J., Fraile A., Nieto A., Beraun Y., Pareja E., Mataran L., et al. Analysis of LMP and TAP polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in rheumatoid arthritis. Ann Rheum Dis 1998, 57:33-37.
19. Maksymowych W.P., Tao S., Vaile J., Suarez-Almazor M., Ramos-Remus C., Russell A.S. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican mestizo patients with ankylosing spondylitis. J Rheumatol 2000, 27:183-189.
20. Lee H.J., Ha S.J., Han H., Kim J.W. Distribution of HLA-A, B alleles and polymorphisms of TAP and LMP genes in Korean patients with atopic dermatitis. Clin Exp Allergy 2001, 31:1867-1874.
21. Mehta A.M., Jordanova E.S., van Wezel T., Uh H.W., Corver W.E., Kwappenberg K.M., et al. Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosomes Cancer 2007, 46:577-586.